MP

Molecular Pharmaceutics

Molecular Pharmaceutics publishes findings on the molecular mechanistic understanding of drug delivery and drug delivery systems.

Looking to publish in Molecular Pharmaceutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Medicine, Research & Experimental, Pharmacology & Pharmacy
Impact Factor 4.5
Quartile Q2
Open Access Type Hybrid
ISSN 1543-8384
eISSN 1543-8392
Invitation Only No
Cost Range No fees for authors under eligible institutional read and publish agreements; read and green agreements may include APC discounts for full open access upgrades.

Submission Instructions

Molecular Pharmaceutics accepts the following article types. Click on an article type to view submission instructions.

Review

Cover Letter Cover Letter requirements are not specified.
Abstract A brief anticipated abstract must be included in the review proposal. Abstract must typically be 150–300 words maximum.
Manuscript Review proposals must be submitted as a single document. The submission must include a proposed title, names and affiliations and websites of corresponding authors, a summary of the authors’ expertise supported by related publications, and a statement explaining how the proposed review differs from recent reviews or perspectives on the topic.
References The review proposal must include 5–10 key references that may form the foundation of the manuscript.
Figures & Tables Figures, charts, tables, schemes, and equations should be embedded in the text at the point of relevance.
Reformat to Molecular Pharmaceutics using Livewrite Premium

Research Articles

Cover Letter A cover letter must accompany every manuscript submission.
Abstract An abstract is required for Research Articles. Abstract must typically be 150–300 words maximum. Abstract should be unstructured.
Manuscript Manuscript must use clearly identified standard sections for original research, including an Introduction, an Experimental Section, and a single-paragraph Conclusions section. Manuscript must include a graphical summary for the table of contents, 5–6 significant keywords after the abstract, and any AI-use disclosure in the Acknowledgments or Methods as appropriate.
References References and notes must be numbered consecutively in order of mention and cited in the text with superscript numbers, and titles must be included for initial submission.
Figures & Tables Figures, charts, tables, schemes, and equations should be embedded in the text at the point of relevance, while Supporting Information must be submitted as separate files. Each figure must have a caption below it and each table must have a brief title describing its contents.
Reformat to Molecular Pharmaceutics using Livewrite Premium

Communication

Cover Letter A cover letter must accompany the submission.
Abstract An abstract is required. Abstract must be less than 100 words.
Manuscript Communications are generally limited to five journal pages. Initial submission must use clearly identified standard sections for reporting original research. Manuscript must include a graphical summary for the table of contents and 5–6 significant keywords after the abstract.
References Communications may contain up to 50 references. References must be numbered consecutively in order of mention in the text and cited with superscript numbers.
Figures & Tables Figures, charts, tables, schemes, and equations should be embedded in the text at the point of relevance. Each figure must have a caption below it, and each table must have a brief title describing its contents.
Reformat to Molecular Pharmaceutics using Livewrite Premium

Recent Publications

Synthesis and Preliminary Evaluation of the 211 At-Labeled PARP Inhibitor [ 211 At]Talazoparib as a Targeted Alpha-Particle Emitting Therapeutic

Yongxiang Zheng, Deyu Kong, Truc T. Huynh, Xiaoguang Zhao, Yang Liu, Rebecca L. Banks, Ganesan Vaidyanathan, Yutian Feng, Michael R. Zalutsky

10.1021/acs.molpharmaceut.6c00367
View Publication

Exosome Nanotherapy Rescues Male Fertility by Delivering Integrin β1 to Repair Environmental Stress-Damaged Testes

Jiahua Meng, Jingyue Wang, Zengfeng Li, Fei Li, Xiang Yun, Yulan Jin, Lin Zhang

10.1021/acs.molpharmaceut.6c00656
View Publication

Development and Evaluation of an Albumin-Binding GPC3-Targeting Peptide for PET Imaging of Hepatocellular Carcinoma

Wenzhu Hu, Lixia Feng, Yan Wang, Zhaoguo Lin, Yuan Feng, Xingyi Wang, Yupin Tan, Dawei Jiang, Mengting Li, Weijun Wei, Xiaoli Lan

10.1021/acs.molpharmaceut.6c00222
View Publication

Visualizing the Spatiotemporal Redistribution of Drugs in Destabilizing Nanoemulsions: A Quantitative Solution 1 H NMR Approach

Keisuke Ueda, Saeko Tomita, Yushi Sunazuka, Kenjirou Higashi, Kunikazu Moribe

10.1021/acs.molpharmaceut.6c00346
View Publication

Correction to “Pharmacokinetics, Biodistribution, Immunogenicity, and Model-Informed-Based PK/PD Model of a Next-Generation Advanced Novel Gene Therapy for Hemophilia”

Dehu Dou, Jing Lu, Peixin Sangchen, Chaorui Guo, Deli Li, Fengxia He, Xi Zhu, Xuefeng Zhang, Xijing Chen

10.1021/acs.molpharmaceut.6c00625
View Publication

Frequently asked questions

How long does it take to publish?

Significant delays in the peer review process can occur if crystallographic information files are not submitted in advance.

Reformat to Molecular Pharmaceutics using Livewrite Premium

Is a cover letter required?

A cover letter must accompany every manuscript submission. It should state the innovation or novelty of the manuscript and provide the name and email address of the corresponding author. Revised manuscripts should include a cover letter describing the changes and revisions. Preprint use should be noted in the cover letter. Crystal structure submissions should notify the editor in the cover letter that structural data accompanies the manuscript.

Reformat to Molecular Pharmaceutics using Livewrite Premium

What are the publication costs?

No fees for authors under eligible institutional read and publish agreements; read and green agreements may include APC discounts for full open access upgrades.

Reformat to Molecular Pharmaceutics using Livewrite Premium

Research Topics

RNA Interference and Gene Delivery Nanoparticle-Based Drug Delivery Drug Solubulity and Delivery Systems Drug Transport and Resistance Mechanisms Nanoplatforms for cancer theranostics Advanced Drug Delivery Systems Advanced biosensing and bioanalysis techniques Crystallization and Solubility Studies Monoclonal and Polyclonal Antibodies Research Protein purification and stability Radiopharmaceutical Chemistry and Applications Analytical Chemistry and Chromatography Peptidase Inhibition and Analysis Computational Drug Discovery Methods Immunotherapy and Immune Responses Advancements in Transdermal Drug Delivery Lipid Membrane Structure and Behavior Dendrimers and Hyperbranched Polymers Virus-based gene therapy research Crystallography and molecular interactions Inhalation and Respiratory Drug Delivery Pharmacological Effects and Toxicity Studies Pharmacogenetics and Drug Metabolism Glycosylation and Glycoproteins Research Surfactants and Colloidal Systems

Related Journals

Cy
Cytotherapy Elsevier BV
JO
Journal of Ethnobiology and Ethnomedicine BioMed Central
DS
Drug Safety Adis, Springer Healthcare
CM
Chinese Medicine BioMed Central
AO
Archives of Medical Research Elsevier BV
IJ
International Journal of Nanomedicine Dove Medical Press